• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大规模组织干预以提高英国四家医院的患者安全:混合方法评估。

Large scale organisational intervention to improve patient safety in four UK hospitals: mixed method evaluation.

机构信息

School of Health and Population Sciences, University of Birmingham, Edgbaston, West Midlands B15 2TT, UK.

出版信息

BMJ. 2011 Feb 3;342:d195. doi: 10.1136/bmj.d195.

DOI:10.1136/bmj.d195
PMID:21292719
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3033440/
Abstract

OBJECTIVES

To conduct an independent evaluation of the first phase of the Health Foundation's Safer Patients Initiative (SPI), and to identify the net additional effect of SPI and any differences in changes in participating and non-participating NHS hospitals.

DESIGN

Mixed method evaluation involving five substudies, before and after design.

SETTING

NHS hospitals in the United Kingdom.

PARTICIPANTS

Four hospitals (one in each country in the UK) participating in the first phase of the SPI (SPI1); 18 control hospitals.

INTERVENTION

The SPI1 was a compound (multi-component) organisational intervention delivered over 18 months that focused on improving the reliability of specific frontline care processes in designated clinical specialties and promoting organisational and cultural change.

RESULTS

Senior staff members were knowledgeable and enthusiastic about SPI1. There was a small (0.08 points on a 5 point scale) but significant (P < 0.01) effect in favour of the SPI1 hospitals in one of 11 dimensions of the staff questionnaire (organisational climate). Qualitative evidence showed only modest penetration of SPI1 at medical ward level. Although SPI1 was designed to engage staff from the bottom up, it did not usually feel like this to those working on the wards, and questions about legitimacy of some aspects of SPI1 were raised. Of the five components to identify patients at risk of deterioration--monitoring of vital signs (14 items); routine tests (three items); evidence based standards specific to certain diseases (three items); prescribing errors (multiple items from the British National Formulary); and medical history taking (11 items)--there was little net difference between control and SPI1 hospitals, except in relation to quality of monitoring of acute medical patients, which improved on average over time across all hospitals. Recording of respiratory rate increased to a greater degree in SPI1 than in control hospitals; in the second six hours after admission recording increased from 40% (93) to 69% (165) in control hospitals and from 37% (141) to 78% (296) in SPI1 hospitals (odds ratio for "difference in difference" 2.1, 99% confidence interval 1.0 to 4.3; P = 0.008). Use of a formal scoring system for patients with pneumonia also increased over time (from 2% (102) to 23% (111) in control hospitals and from 2% (170) to 9% (189) in SPI1 hospitals), which favoured controls and was not significant (0.3, 0.02 to 3.4; P = 0.173). There were no improvements in the proportion of prescription errors and no effects that could be attributed to SPI1 in non-targeted generic areas (such as enhanced safety culture). On some measures, the lack of effect could be because compliance was already high at baseline (such as use of steroids in over 85% of cases where indicated), but even when there was more room for improvement (such as in quality of medical history taking), there was no significant additional net effect of SPI1. There were no changes over time or between control and SPI1 hospitals in errors or rates of adverse events in patients in medical wards. Mortality increased from 11% (27) to 16% (39) among controls and decreased from 17% (63) to 13% (49) among SPI1 hospitals, but the risk adjusted difference was not significant (0.5, 0.2 to 1.4; P = 0.085). Poor care was a contributing factor in four of the 178 deaths identified by review of case notes. The survey of patients showed no significant differences apart from an increase in perception of cleanliness in favour of SPI1 hospitals.

CONCLUSIONS

The introduction of SPI1 was associated with improvements in one of the types of clinical process studied (monitoring of vital signs) and one measure of staff perceptions of organisational climate. There was no additional effect of SPI1 on other targeted issues nor on other measures of generic organisational strengthening.

摘要

目的

对健康基金会更安全患者倡议(SPI)第一阶段进行独立评估,并确定 SPI 的净附加效果以及参与和不参与 NHS 医院的变化差异。

设计

包含五项子研究的混合方法评估,采用前后设计。

设置

英国 NHS 医院。

参与者

参与 SPI1 的四家医院(英国每个国家各一家);18 家对照医院。

干预措施

SPI1 是一项在 18 个月内实施的复合(多成分)组织干预措施,重点是提高指定临床专业中特定一线护理流程的可靠性,并促进组织和文化变革。

结果

高级工作人员对 SPI1 了解并热情。在员工问卷的 11 个维度之一(组织氛围)中,SPI1 医院有一个小(5 分制 0.08 分)但显著(P < 0.01)的优势。定性证据表明,SPI1 仅在医疗病房层面略有渗透。尽管 SPI1 旨在自下而上地让员工参与,但对于在病房工作的人来说,这感觉并不总是如此,并且对 SPI1 某些方面的合法性提出了质疑。在确定可能恶化的患者的五个组成部分中——监测生命体征(14 项);常规检查(三项);针对特定疾病的循证标准(三项);处方错误(来自英国国家处方集的多项条目);和医疗史记录(11 项)——除了与急性内科患者监测质量有关的方面外,对照组和 SPI1 医院之间几乎没有净差异,所有医院的监测质量都随着时间的推移而有所提高。在 SPI1 医院中,呼吸频率的记录增加到更大的程度;在入院后第二六小时,对照组的记录从 40%(93 人)增加到 69%(165 人),SPI1 医院从 37%(141 人)增加到 78%(296 人)(差异比 2.1,99%置信区间 1.0 至 4.3;P = 0.008)。用于肺炎患者的正式评分系统的使用也随着时间的推移而增加(对照组从 2%(102 人)增加到 23%(111 人),SPI1 医院从 2%(170 人)增加到 9%(189 人)),这有利于对照组,但不显著(0.3,0.02 至 3.4;P = 0.173)。处方错误的比例没有改善,也没有可以归因于 SPI1 的非靶向通用领域的效果。在某些措施上,缺乏效果可能是因为在基线时已经遵守率很高(例如,在需要的情况下,超过 85%的情况下使用类固醇),但即使在有更多改进空间的情况下(例如在医疗史记录质量方面),SPI1 也没有显著的额外净效果。在医疗病房的患者中,没有观察到错误或不良事件发生率随时间或对照和 SPI1 医院的变化。对照组的死亡率从 11%(27 人)增加到 16%(39 人),SPI1 医院的死亡率从 17%(63 人)下降到 13%(49 人),但风险调整差异无统计学意义(0.5,0.2 至 1.4;P = 0.085)。在通过病历审查确定的 178 例死亡病例中,护理不佳是四个死亡病例的一个促成因素。患者调查显示,除了 SPI1 医院的清洁度感知增加外,没有其他显著差异。

结论

SPI1 的引入与研究的一种临床流程类型(生命体征监测)和一种员工对组织氛围感知的衡量标准的改进有关。SPI1 对其他目标问题或其他通用组织强化措施没有额外效果。

相似文献

1
Large scale organisational intervention to improve patient safety in four UK hospitals: mixed method evaluation.大规模组织干预以提高英国四家医院的患者安全:混合方法评估。
BMJ. 2011 Feb 3;342:d195. doi: 10.1136/bmj.d195.
2
Multiple component patient safety intervention in English hospitals: controlled evaluation of second phase.英文医院多环节患者安全干预措施:第二阶段对照评估
BMJ. 2011 Feb 3;342:d199. doi: 10.1136/bmj.d199.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
A methodological study to compare survey-based and observation-based evaluations of organisational and safety cultures and then compare both approaches with markers of the quality of care.一种比较基于调查和基于观察的组织和安全文化评估方法的方法学研究,然后将这两种方法与护理质量的标志物进行比较。
Health Technol Assess. 2012 May;16(25):iii-iv, 1-184. doi: 10.3310/hta16250.
5
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
6
Perceptions of the impact of a large-scale collaborative improvement programme: experience in the UK Safer Patients Initiative.对一项大规模协作改进计划影响的认知:英国患者安全倡议的经验
J Eval Clin Pract. 2009 Jun;15(3):524-40. doi: 10.1111/j.1365-2753.2009.01145.x.
7
Pilot Medical Certification飞行员医学认证
8
Factors predicting change in hospital safety climate and capability in a multi-site patient safety collaborative: a longitudinal survey study.多地点患者安全合作组织中预测医院安全氛围和能力变化的因素:一项纵向调查研究。
BMJ Qual Saf. 2012 Jul;21(7):559-68. doi: 10.1136/bmjqs-2011-000286. Epub 2012 May 5.
9
10
Development and evaluation of a de-escalation training intervention in adult acute and forensic units: the EDITION systematic review and feasibility trial.成人急症和法医病房中降级治疗培训干预措施的制定和评估:EDITION 系统评价和可行性试验。
Health Technol Assess. 2024 Jan;28(3):1-120. doi: 10.3310/FGGW6874.

引用本文的文献

1
Continuous quality improvement across a South Australian health service and the role it plays in a learning health system: a qualitative study.南澳大利亚州一家医疗服务机构的持续质量改进及其在学习型医疗系统中所发挥的作用:一项定性研究
BMC Health Serv Res. 2025 Mar 27;25(1):457. doi: 10.1186/s12913-025-12557-4.
2
Rapid response systems, antibiotic stewardship and medication reconciliation: a scoping review on implementation factors, activities and outcomes.快速反应系统、抗生素管理与用药核对:关于实施因素、活动及结果的范围综述
BMJ Qual Saf. 2025 Mar 19;34(4):257-268. doi: 10.1136/bmjqs-2024-017185.
3
What are the features of high-performing quality improvement collaboratives? A qualitative case study of a state-wide collaboratives programme.

本文引用的文献

1
Multiple component patient safety intervention in English hospitals: controlled evaluation of second phase.英文医院多环节患者安全干预措施:第二阶段对照评估
BMJ. 2011 Feb 3;342:d199. doi: 10.1136/bmj.d199.
2
Evaluating policy and service interventions: framework to guide selection and interpretation of study end points.评估政策和服务干预措施:指导研究终点选择与解读的框架
BMJ. 2010 Aug 27;341:c4413. doi: 10.1136/bmj.c4413.
3
How will it work? A qualitative study of strategic stakeholders' accounts of a patient safety initiative.
高绩效质量改进合作有哪些特点?全州范围合作项目的定性案例研究。
BMJ Open. 2023 Dec 13;13(12):e076648. doi: 10.1136/bmjopen-2023-076648.
4
Quality and reporting of large-scale improvement programmes: a review of maternity initiatives in the English NHS, 2010-2023.大规模改进计划的质量和报告:对 2010-2023 年英国国民保健制度中产科举措的审查。
BMJ Qual Saf. 2024 Oct 18;33(11):704-715. doi: 10.1136/bmjqs-2023-016606.
5
The development of the concept of return-on-investment from large-scale quality improvement programmes in healthcare: an integrative systematic literature review.从医疗保健领域的大规模质量改进计划看投资回报率的概念发展:综合系统文献回顾
BMC Health Serv Res. 2022 Dec 7;22(1):1492. doi: 10.1186/s12913-022-08832-3.
6
Non-invasive sensor methods used in monitoring newborn babies after birth, a clinical perspective.出生后监测新生儿的非侵入性传感器方法:临床视角
Matern Health Neonatol Perinatol. 2022 Nov 22;8(1):9. doi: 10.1186/s40748-022-00144-y.
7
Effect of the Growth Assessment Protocol on the DEtection of Small for GestatioNal age fetus: process evaluation from the DESiGN cluster randomised trial.生长评估方案对小胎龄儿检出率的影响:DESiGN 集群随机试验的过程评价。
Implement Sci. 2022 Sep 5;17(1):60. doi: 10.1186/s13012-022-01228-1.
8
Identifying and understanding benefits associated with return-on-investment from large-scale healthcare Quality Improvement programmes: an integrative systematic literature review.识别和理解与大型医疗保健质量改进计划投资回报率相关的收益:综合系统文献回顾。
BMC Health Serv Res. 2022 Aug 24;22(1):1083. doi: 10.1186/s12913-022-08171-3.
9
Can inverse probability treatment weighting (IPTW) be used to assess differences of CRBSI rates between non-tunneled femoral and jugular CVCs in PICU patients?可否采用逆概率处理加权法(IPTW)来评估 ICU 患者中非隧道式股静脉和颈内静脉中央导管(CVC)的中心导管相关血流感染(CRBSI)发生率差异?
BMC Infect Dis. 2022 Jul 7;22(1):598. doi: 10.1186/s12879-022-07571-4.
10
Effectiveness of Enhanced Performance Feedback on Appropriate Use of Blood Transfusions: A Comparison of 2 Cluster Randomized Trials.增强型绩效反馈对输血合理应用效果的影响:两项群组随机试验比较。
JAMA Netw Open. 2022 Feb 1;5(2):e220364. doi: 10.1001/jamanetworkopen.2022.0364.
它将如何运作?一项关于战略利益相关者对患者安全倡议描述的定性研究。
Qual Saf Health Care. 2010 Feb;19(1):74-8. doi: 10.1136/qshc.2008.029504.
4
Studying large-scale programmes to improve patient safety in whole care systems: challenges for research.研究改善整个医疗体系患者安全的大规模项目:研究面临的挑战。
Soc Sci Med. 2009 Dec;69(12):1767-76. doi: 10.1016/j.socscimed.2009.09.051. Epub 2009 Oct 23.
5
An ethnographic study of classifying and accounting for risk at the sharp end of medical wards.对医疗病房风险进行分类和核算的民族志研究。
Soc Sci Med. 2009 Aug;69(3):362-9. doi: 10.1016/j.socscimed.2009.05.025. Epub 2009 Jun 15.
6
Evaluating service delivery interventions to enhance patient safety.评估旨在提高患者安全的服务提供干预措施。
BMJ. 2008 Dec 17;337:a2764. doi: 10.1136/bmj.a2764.
7
The SQUIRE (Standards for QUality Improvement Reporting Excellence) guidelines for quality improvement reporting: explanation and elaboration.质量改进报告的SQUIRE(卓越质量改进报告标准)指南:解释与详述
Qual Saf Health Care. 2008 Oct;17 Suppl 1(Suppl_1):i13-32. doi: 10.1136/qshc.2008.029058.
8
An epistemology of patient safety research: a framework for study design and interpretation. Part 4. One size does not fit all.患者安全研究的认识论:研究设计与解读框架。第4部分。一刀切并不适用。
Qual Saf Health Care. 2008 Jun;17(3):178-81. doi: 10.1136/qshc.2007.023663.
9
An epistemology of patient safety research: a framework for study design and interpretation. Part 3. End points and measurement.患者安全研究的认识论:研究设计与解读框架。第3部分。终点与测量。
Qual Saf Health Care. 2008 Jun;17(3):170-7. doi: 10.1136/qshc.2007.023655.
10
An epistemology of patient safety research: a framework for study design and interpretation. Part 2. Study design.患者安全研究的认识论:研究设计与解读框架。第二部分。研究设计。
Qual Saf Health Care. 2008 Jun;17(3):163-9. doi: 10.1136/qshc.2007.023648.